AI assistant
AtriCure, Inc. — Director's Dealing 2016
Feb 16, 2016
31802_dirs_2016-02-16_9749986f-8622-4276-aa0b-db154ee8688c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2016-02-03
Reporting Person: Noznesky Justin J (SVP, Mktg & Business Develop)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 70183 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $18.30 | 2024-01-06 | Common Stock (60000) | Direct |
Footnotes
F1: Includes 12,500 shares of unvested restricted stock awarded under the AtriCure, Inc. 2005 Equity Incentive Plan and 50,000 shares of unvested restricted stock awarded under the AtriCure, Inc. 2014 Stock Incentive Plan, which vest 25% annually over four years from date of grant.
F2: The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.